Situation: The nurse works in the critical care area of an emergency department that receives acutely ill adults. None of the clients below is pregnant. Another client with a hypertensive emergency and acute heart failure is started on sodium nitroprusside. Which nursing action is correct?

Sodium nitroprusside breaks down in light, so the bag is protected with an opaque cover. It must be diluted and given only by infusion pump with continuous arterial blood pressure monitoring, because it can cause sudden severe hypotension; prolonged or high-dose use can cause cyanide toxicity.

Core principle Sodium nitroprusside is a rapid-acting arterial and venous vasodilator used for hypertensive emergencies and acute heart failure, but its safe administration depends on protecting the drug from light, diluting it properly, and monitoring blood pressure continuously. The correct nursing action is to shield the infusion bag from light.

Why light protection is essential Nitroprusside is a photolabile compound. When the solution is exposed to light, the drug undergoes photodegradation, which causes two clinically important problems. First, the active drug loses potency, so the patient may not receive the intended antihypertensive effect. Second, and more dangerous, light-induced breakdown releases cyanide and nitric oxide from the nitroprusside molecule. Exposing the infusion to white or blue light accelerates degradation, whereas red light does not produce the same effect ^[3]. Therefore, the infusion bag and tubing should be wrapped in an opaque cover to maintain drug stability and minimize cyanide formation.

Stability in protected containers When the solution is kept in light-protected glass or plastic containers, nitroprusside remains stable in common diluents such as 5% dextrose, normal saline, and lactated Ringer’s solution ^[4]. Simulated infusion studies show no decrease in delivered potency for up to 24 hours when the system is protected from light ^[4]. This supports the practice of preparing the infusion in a light-shielded bag and using opaque or light-resistant tubing.

Why the other options are incorrect

Option	Reason it is incorrect
1. Check blood pressure with an arm cuff every hour	Hourly cuff checks are insufficient. Nitroprusside can cause sudden, profound hypotension within minutes. Continuous intra-arterial blood pressure monitoring is recommended during infusion.
3. Flush the line with saline whenever the pump alarms	Flushing the line can deliver a bolus of concentrated nitroprusside, causing dangerous hypotension. When the pump alarms, the nurse should troubleshoot the occlusion or air-in-line without flushing the drug line.
4. Give the first dose as a slow undiluted intravenous push	Nitroprusside must never be given by IV push. It requires dilution and administration only by a controlled infusion pump with continuous hemodynamic monitoring.

Cyanide toxicity and monitoring Nitroprusside is metabolized to cyanide, which is normally converted to thiocyanate and excreted. However, prolonged infusion, high doses, or renal impairment can lead to cyanide accumulation and toxicity . Signs of cyanide toxicity include altered mental status, metabolic acidosis, tachyphylaxis to the drug’s effect, and cardiovascular collapse. The FDA labeling change emphasized this pharmacokinetic risk . Key point! Co-infusion of sodium thiosulfate provides a sulfur donor that helps convert cyanide to the less toxic thiocyanate, a preventive strategy sometimes used in practice .

Clinical application for the critical care nurse When caring for a client receiving nitroprusside, the nurse should verify that the solution is diluted, the infusion pump is programmed correctly, the bag and tubing are shielded from light, and arterial blood pressure is monitored continuously. Watch out! Never flush the line or change the infusion rate abruptly without considering the risk of a bolus effect. The light-protection step is a simple but non-negotiable safety measure that directly prevents both loss of drug potency and increased cyanide exposure.